Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Korzeniewska-Kosela (Warsaw, Poland). Risk factors for anti-TB drug resistance in Poland. Eur Respir J 2013; 42: Suppl. 57, 4464

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for tuberculosis relapse in Polish patients Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Risk factors for acquired drug-resistant tuberculosis Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Trends of MBT drug resistance Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Tuberculosis and HIV infection in combination with multidrug resistant MBT on Northwest of Russia Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016 Current status of fluoroquinolone use for treatment of tuberculosis in Korea Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Dynamics of primary multidrug drug resistance in Novokuznetsk over 10 years period Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology Year: 2016 Risk factor and resistance pattern of MDR TB among suspected cases of Oromia Region Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015 Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia) Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 MDR TB treatment results of GFATM program implementation in Tomsk, Russia Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Drug resistance among new TB cases in some Russian regions Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015 Impact of drug injection using on TB-AIDS treatment outcomes Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Failure predictors when treating MDR-TB Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Nationwide anti-tuberculosis drug resistance survey in the Republic of Azerbaijan Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Spectrum of adverse drug reactions during MDR TB treatment Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Effectiveness of national standardized and WHO regimens and risk factors of unfavorable outcomes in treatment of patients with MDR-TB in Novosibirsk Oblast, Russian Federation Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 Clinical experience of clofazimine in the treatment of MDR-TB Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013